Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Inventory (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Inventory for 16 consecutive years, with $4.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Inventory fell 32.68% year-over-year to $4.0 million, compared with a TTM value of $4.0 million through Sep 2025, down 32.68%, and an annual FY2024 reading of $5.8 million, down 1.58% over the prior year.
  • Inventory was $4.0 million for Q3 2025 at Rockwell Medical, down from $4.2 million in the prior quarter.
  • Across five years, Inventory topped out at $6.1 million in Q1 2024 and bottomed at $4.0 million in Q3 2025.
  • Average Inventory over 5 years is $5.2 million, with a median of $5.5 million recorded in 2023.
  • The sharpest move saw Inventory surged 42.64% in 2022, then plummeted 32.68% in 2025.
  • Year by year, Inventory stood at $4.1 million in 2021, then soared by 42.64% to $5.8 million in 2022, then grew by 0.98% to $5.9 million in 2023, then decreased by 1.58% to $5.8 million in 2024, then plummeted by 31.39% to $4.0 million in 2025.
  • Business Quant data shows Inventory for RMTI at $4.0 million in Q3 2025, $4.2 million in Q2 2025, and $5.0 million in Q1 2025.